Pipeline

Qiagen has moved into syndromic testing for bloodstream infections with the launch of its newest offering.…

While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public healt…

More than a year after licensing its PD-1xVEGF bispecific, Merck & Co. has finally unveiled the first clin…

Many gene therapy outfits focus on technical advances, Ocugen CEO Shankar Musunuri, Ph.D., said, meaning they …

Rather than relying on patient groups to make an impassioned plea, Roche aims to put doubts to rest around the…

Travere is eyeing a collective $3 billion U.S. opportunity for Filspari thanks to a new rare kidney disease no…